Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denys

Showing results (131-140 of 170) with videos related to

Pageof 17
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 27, 2009
[Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity]B Perrouin-Verbe, A Ruffion, X Gamé, et al.
Bjpsych Open|March 2, 2023
Ethnic differences in response to atypical antipsychotics in patients with schizophrenia: individual patient data meta-analysis of randomised placebo-controlled registration trials submitted to the Dutch Medicines Evaluation BoardBram W C Storosum, Cedrine Steinz, Sem E Cohen, et al.
Annales De Readaptation Et De Medecine Physique : Revue Scientifique De La Societe Francaise De Reeducation Fonctionnelle De Readaptation Et De Medecine Physique|June 3, 2008
[Patient follow-up after botulinum toxin intradetrusor injection. Proposal for management in neurogenic patients]M de Sèze, A Ruffion, F Haab, et al.
Social Psychiatry and Psychiatric Epidemiology|January 24, 2013
Annual incidence rate of schizophrenia and schizophrenia spectrum disorders in a longitudinal population-based cohort studyArjen L Sutterland, Jeanne Dieleman, Jitschak G Storosum, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2020
Apathy Induced by Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A Meta-AnalysisThomas J C Zoon, Geeske van Rooijen, Georgina M F C Balm, et al.
Tijdschrift Voor Psychiatrie|April 25, 2019
[Reaction on 'Persistant underuse of ECT for persistant depressive disorder?']D S Scheepens, J A van Waarde, A Lok, et al.
BMJ Open|June 23, 2022
Augmenting neurocognitive remediation therapy to Preventive Cognitive Therapy for partially remitted depressed patients: protocol of a pragmatic multicentre randomised controlled trialClaudi Bockting, Amanda M Legemaat, Johanne G J van der Stappen, et al.
Tijdschrift Voor Psychiatrie|January 15, 2019
[Electroconvulsion therapy for persistent depression in the Netherlands; very low application rate]D S Scheepens, J A van Waarde, A Lok, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 25, 2015
Placebo response in antipsychotic trials of patients with acute mania: Results of an individual patient data meta-analysisC C M Welten, M W J Koeter, T Wohlfarth, et al.
International Clinical Psychopharmacology|June 13, 2009
Prescription of antipsychotic medication to patients at ultra high risk of developing psychosisDorien H Nieman, Wera H Rike, Hiske E Becker, et al.
Pageof 17

Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 27, 2009
[Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity]B Perrouin-Verbe, A Ruffion, X Gamé, et al.
Bjpsych Open|March 2, 2023
Ethnic differences in response to atypical antipsychotics in patients with schizophrenia: individual patient data meta-analysis of randomised placebo-controlled registration trials submitted to the Dutch Medicines Evaluation BoardBram W C Storosum, Cedrine Steinz, Sem E Cohen, et al.
Annales De Readaptation Et De Medecine Physique : Revue Scientifique De La Societe Francaise De Reeducation Fonctionnelle De Readaptation Et De Medecine Physique|June 3, 2008
[Patient follow-up after botulinum toxin intradetrusor injection. Proposal for management in neurogenic patients]M de Sèze, A Ruffion, F Haab, et al.
Social Psychiatry and Psychiatric Epidemiology|January 24, 2013
Annual incidence rate of schizophrenia and schizophrenia spectrum disorders in a longitudinal population-based cohort studyArjen L Sutterland, Jeanne Dieleman, Jitschak G Storosum, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2020
Apathy Induced by Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A Meta-AnalysisThomas J C Zoon, Geeske van Rooijen, Georgina M F C Balm, et al.
Tijdschrift Voor Psychiatrie|April 25, 2019
[Reaction on 'Persistant underuse of ECT for persistant depressive disorder?']D S Scheepens, J A van Waarde, A Lok, et al.
BMJ Open|June 23, 2022
Augmenting neurocognitive remediation therapy to Preventive Cognitive Therapy for partially remitted depressed patients: protocol of a pragmatic multicentre randomised controlled trialClaudi Bockting, Amanda M Legemaat, Johanne G J van der Stappen, et al.
Tijdschrift Voor Psychiatrie|January 15, 2019
[Electroconvulsion therapy for persistent depression in the Netherlands; very low application rate]D S Scheepens, J A van Waarde, A Lok, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 25, 2015
Placebo response in antipsychotic trials of patients with acute mania: Results of an individual patient data meta-analysisC C M Welten, M W J Koeter, T Wohlfarth, et al.
International Clinical Psychopharmacology|June 13, 2009
Prescription of antipsychotic medication to patients at ultra high risk of developing psychosisDorien H Nieman, Wera H Rike, Hiske E Becker, et al.
Pageof 17